Options

Notable Tuesday Option Activity: SGEN, HUM, GOOGL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Seagen Inc (Symbol: SGEN), where a total volume of 13,501 contracts has

Options

Notable Tuesday Option Activity: SGEN, HUM, GOOGL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Seagen Inc (Symbol: SGEN), where a total volume of 13,501 contracts has

More top news

In case you missed it

Top of the month

Zydus Lifesciences shares gain following USFDA approval for Tofacitinib tablets

The drug will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad (India). Zydus Lifesciences ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’] >= 0){ $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $(‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] < 0){ $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); //$(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); $(‘#gainlosstxt_’+articleId).find(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); }

Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

Lenalidomide Capsules works by slowing or stopping the growth of cancer cells.

Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

Lenalidomide Capsules works by slowing or stopping the growth of cancer cells. Zydus Lifesciences ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’] >= 0){ $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $(‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] < 0){ $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); //$(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); $(‘#gainlosstxt_’+articleId).find(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); } $(‘#volumetxt_’+articleId).show(); $(‘#vlmtxt_’+articleId).show();

Pretty much everything about Meta Platforms (NASDAQ: META) and CEO Mark Zuckerberg is divisive these days. So it comes as no surprise that the company’s new premium virtual reality (VR) headset, Meta Quest Pro, was received with disdain by many in the media. Hating on VR, the met

Weekly Top

more news